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Summary  Little  is  known  about  the  effectiveness  of  disinfectants  against  human
noroviruses  (NoV)  partially  because  human  NoV  cannot  be  routinely  cultured  in
laboratory.  The  objective  of  this  study  was  to  develop  a  NoV  monoclonal  antibody-
conjugated  immunomagnetic  separation  (IMS)  procedure  combined  with  real-time
reverse  transcription  polymerase  chain  reaction  (RT-qPCR)  assays  to  study  the
in  vitro  efﬁcacy  of  disinfectants  against  human  NoV.  Monoclonal  antibodies  against
Norwalk  virus  (NV,  GI.1)  and  NoV  GII.4  were  produced  using  unique  NoV  capsid
proteins,  and  the  antibodies  were  conjugated  to  magnetic  Dynalbeads.  The  immuno-
magnetic  beads  were  used  to  simultaneously  capture  intact  NoV  in  samples  and
effectively  remove  PCR  inhibitors.  We  examined  the  efﬁcacy  of  ethanol,  sodium
hypochlorite,  nine  commercially  available  disinfectants,  and  one  prototype  disin-
fectant  using  the  IMS/RT-qPCR.  The  sensitivity  of  this  procedure  was  approximately
100  virus  particles  for  both  the  NV  and  GII.4  viruses.  The  average  log  reductions  in
in  vitro  activities  varied  between  disinfectants.  The  prototype  disinfectant  produced
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an  average  3.19-log  reduction  in  NV  and  a 1.38-log  reduction  in  GII.4.  The  prototype
disinfectant  is  promising  of  inactivating  NoV.  This  method  can  be  used  to  evaluate
in  vitro  activity  of  disinfectants  against  human  NoV.  The  IMS/RT-qPCR  method  is
promising  as  an  effective  method  to  remove  PCR  inhibitors  in  disinfectants  and  enable
the  evaluation  of  the  efﬁcacy  of  disinfectants.
©  2014  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  Published  by  Elsevier
Ltd.  All  rights  reserved.
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were evaluated.  An  experimental  negative  control
(DNase-  and  RNase-free  deionized  water)  served
to represent  the  input  virus.  A  product  negativeIntroduction
Noroviruses  (NoV)  are  a  leading  cause  of  acute  non-
bacterial  gastroenteritis  outbreaks  in  adults  [1]  and
the second  most  important  viral  pathogen  of  acute
nonbacterial  gastroenteritis  in  young  children  [2].
These viruses  are  classiﬁed  into  ﬁve  genogroups
(GI to  GV),  and  each  genogroup  is  further  divided
into multiple  clusters  [3].  Norwalk  virus  (NV)  is  the
prototype  of  the  GI  group,  and  GII.4  is  the  predom-
inant epidemic  strain  that  accounted  for  62%  of  all
reported NoV  outbreaks  from  2001  to  2007  in  the
US [4].  GII.4  is  also  the  most  commonly  reported
genotype in  pediatric  NoV  infections  [5,6].
NoV are  readily  transmitted  in  human  popula-
tions by  the  consumption  of  contaminated  food,
water,  contact  between  individuals,  and  contam-
inated inanimate  surfaces.  Because  these  viruses
are highly  contagious  among  humans  [7],  persistent
in environments  [8], and  resistant  to  disinfec-
tants [9],  prevention  and  control  of  outbreaks
and sporadic  diarrhea  is  challenging.  Among  the
possible effective  measures,  the  disinfection  of
contaminated  surfaces  is  an  effective  strategy  for
interrupting  NoV  transmission  [10]; however,  little
is known  about  the  effectiveness  of  disinfectants
against human  NoV  [11,12].  One  reason  for  this
lack of  knowledge  is  that  human  NoV  cannot  be
routinely  cultured  in  vitro,  which  complicates  the
evaluation  of  the  efﬁcacies  of  disinfection  strate-
gies. As  there  is  no  in  vitro  culture  system  for
human NoV  (HuNoV),  nucleic  acid-based  diagnostic
methods  have  been  the  dominant  tools.  However,
there are  two  major  obstacles  to  the  use  of  these
nucleic acid-based  detection  tools  in  the  evaluation
of disinfectants:  (1)  the  presence  of  PCR  inhibitors
in disinfectants  and  virus  stocks  that  usually  apply
human fecal  specimens,  and  (2)  the  inability  to
c
o
pbtain  intact  virions.  One  approach  to  removing
CR inhibitors  and  allowing  for  the  detection  of
ntact virions  is  the  use  speciﬁc  virus  antibody-
ediated immunomagnetic  separation  (IMS)  assays.
MS assays  can  potentially  effectively  and  simul-
aneously  remove  PCR-inhibiting  substances  and
apture intact  virions  to  allow  for  subsequent
uantitative  real-time  RT-PCR  (RT-qPCR)  that  only
uantiﬁes  the  intact  virions  (Fig.  1).  IMS  assays
ave been  reported  to  successfully  isolate  human
oroviruses  from  contaminated  food  [13], environ-
ental  water  [14], and  stool  samples  [15],  but
uch assays  have  not  been  used  to  study  the  efﬁ-
acy of  disinfectants  against  HuNoV.  The  objective
f this  study  was  to  develop  a NoV  monoclonal
ntibody-conjugated  IMS  procedure  combined  with
oV RT-qPCR  assays  to  study  the  in  vitro  efﬁcacy  of
isinfectants  against  GI.1  and  GII.4.  We  examined
he efﬁcacies  of  ethanol,  sodium  hypochlorite,  nine
ommercially  available  disinfectants,  and  one  pro-
otype disinfectant  developed  by  Kim  Laboratories
nc. (Kim  Laboratories  Inc,  Rantoul,  IL,  USA).
aterials and methods
est disinfectants and controls
 total  of  10  disinfectants  (Table  1),  including
ine commercial  disinfectants  and  one  prototype
isinfectant provided  by  Kim  Laboratories  Inc.,ontrol (70%  ethanol)  with  previous  evidence  [16]
f  ineffectiveness  against  HuNoV  and  a product
ositive control  (sodium  hypochlorite)  that  has
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vigure  1  Diagram  illustrating  the  procedures  for  the  is
oated  with  anti-norovirus  antibodies.
hown  complete  inactivation  of  HuNoV  [16]  were
rocessed  under  ambient  temperature  (70—74 ◦F
21—23 ◦C])  using  the  same  laboratory  procedures
hat were  employed  for  the  test  products.
uman norovirus inoculum
orwalk  virus  was  obtained  from  the  stool  sam-
le of  an  infected  volunteer  in  a  previous  human
hallenge study  [17]. GII.4  norovirus  was  obtained
rom  an  outbreak  and  was  conﬁrmed  by  RT-PCR
nd sequencing.  The  stool  samples  were  diluted
o 20%  suspensions  in  RNase-free  water,  vortexed
rieﬂy, and  centrifuged  at  550  ×  g  for  30  s.  Aliquots
f the  supernatants  were  used  as  the  sources  of  the
iruses.
onoclonal antibodies against NV and GII.4
he  monoclonal  antibodies  (mAbs)  to  NV  (Cata-
og number  MABG12)  and  GII.4  (Catalog  number
ABG22) were  produced  by  Kim  Laboratories  Inc.
hese mAbs  were  generated  by  immunizing  mice
sing  unique  NoV  capsid  antigens  identiﬁed  by  Kim
aboratories.  According  to  the  general  guidelines
f monoclonal  antibody  production,  the  antigens
ere conjugated  to  the  carrier  immunogen  keyhole
I
S
ton  of  norovirus  from  the  samples  using  magnetic  beads
impet  hemocyanin  to  ensure  high-yield  antibody
roduction  and  injected  into  mice  (i.p.)  twice  over
 6-week  time  period.  Next,  the  sera  were  collected
rom immunized  mice  and  assayed  for  NoV  antibody
roduction  against  the  immunized  antigens  using
n enzyme  immunoassay  (EIA).  The  mice  with  pos-
tive antibody  reactions  were  given  a ﬁnal  boost
mmunization  prior  to  fusion  of  the  spleen  cells  with
he Sp2/O  myeloma  cell  line.  The  resultant  fusion
ybridomas  were  screened  for  reactivity  against  the
ntigens and  NoV  VLPs  (Virus-like  Particles)  using
IA.
onjugation of antibodies to IMS beads
ommercially  available  M-280  Dynalbeads  (Dynal
iotech,  Oslo,  Norway)  were  used  for  conjugation
o the  NoV  antibodies.  Fifty  milligrams  of  the  beads
ere conjugated  with  2  mg  of  the  antibody  accord-
ng to  the  manufacturer’s  instructions.  The  ﬁnal
oncentration  of  IMS  bead  was  20  mg/mL  in  the  pro-
ided buffer.n vitro suspension procedure
uspension  tests  for  the  virucidal  activities  of
he disinfectants  were  performed  as  described
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Table  1  Test  products  and  ingredients.
Test  product
(vendor)
Active  ingredient  and  concentration  (%)a Other  ingredientsa Affected  microorganismsa Application  recommendationa
Daesung
(Daesung  C&C,
Korea)
Hydrogen  peroxide  (22%),  acetate  (6%),
dehydroacetic  acid  (4%)
95.26%  other  ingredients  Kills  a  wide  variety  of
organisms  including  a  list  of
respiratory  and  enteric
bacteria  and  viruses
Dilute  1:500  with  water  for
ready  to  use  solution.  4  min
exposure  of  the  disinfectant
to  target  pathogens
Ajax  D-125  formula
(Microgen  Inc.,
NJ  USA)
2.37%  Alkyl  (60%  C14,  30%  C16, 5%  C12,  5%
C18)  dimethyl  benzyl  ammonium  chloride;
2.37%  alkyl  (68%  C12,  32%  C14)  dimethyl
ethylbenzyl  ammonium  chloride
95.26%  inert  ingredients  Kills  141  microorganisms
including  bacteria,  antibiotic
resistant  bacteria  and  viruses
Dilute  1:64  with  water  for
ready  to  use  solution.  4  min
exposure  of  the  disinfectant
to  target  pathogens
Clorox  Disinfectant
Wipes
(Clorox,  USA)
0.145%  alkyl  (C12—C16)  benzyl  ammonium
chloride;  0.145%  alkyl  (C12—C18)
ethylbenzyl  ammonium  chloride
1.0—5.0%  isopropanol
94.71—98.71%  other
ingredients
Kills  99%  bacteria  in  15  s;  kill
ﬂu  virus,  HIV,  MRSA/STAPH
Wipe  disinfecting  areas
Vital  Oxide
(Vital  Oxide,  USA)
0.2%  Chlorine  dioxide;  0.125%  alkyl  (60%
C14,  30%  C16,  5%  C12,  5%  C18)  dimethyl
benzyl  ammonium  chloride;  0.125%  alkyl
(68%  C12,  32%  C14)  dimethyl  ethylbenzyl
ammonium  chloride
99.55%  other  ingredients  Kills  a  wide  variety  of
organisms  including  a  list  of
respiratory  and  enteric
bacteria  and  viruses  and
hepatitis  B  and  C  viruses.
Use  as  is.  Allow  surfaces  to
remain  wet  for  5  min  for  virus
inactivation  and  10  min  for
bacteria  disinfection
Aseptic-HBTM
(Ecolab,  USA)
0.07%  Alkyl  (60%  C14,  30%  C16, 5%  C12,  5%
C18)  dimethyl  benzyl  ammonium  chloride;
0.07%  alkyl  (68%  C12 and  32%  C14)
dimethyl  ethylbenzyl  ammonium  chloride
99.86%  inert  ingredients Against  hepatitis  B  virus,
virucidal,  bactericidal,
fungicidal  and  HIV-1
Use  as  is.  Use  10  min  contact
time  for  other  viruses,
bacteria  and  fungi
SaniClean  Quat
(Namkang,  Korea)
17.5%  Alkyl  (C12—C18)  dimethyl
ammonium  chlorides;  5%
ethylenediaminetetraacetic  acid
77.5%  inert  ingredients  Both  Gram  positive  and
negative  bacteria,  fungi,  and
viruses
Dilute  1:500  with  water.
Allow  surface  to  remain  wet
for  5  min  for  disinfection
Lysol® 4  in  1
(Reckitt
Benckiser,  UK)
0.086%  alkyl  (67%  C12,  25%  C14, 7%  C16,  1%
C8—C10—C18)  dimethyl  benzyl  ammonium
chloride;  0.0216%  alkyl  (68%  C12 and  32%
C14)  dimethyl  ethylbenzyl  ammonium
chloride
3.2%  lactic  acid
96.7%  other  ingredients
including  dipropylene  glycol
monobutyl  ether,  alcohols,
ethoxylated,  sulfonic  acids
Eliminates  odor-causing
bacteria  and  kill  the  ﬂu  virus;
kills  99.9%  viruses  and
bacteria
Leave  surfaces  wet  for  10  min
Oxivir-TB
(JohnsonDiversey
Inc,  USA)
0.5%  Hydrogen  Peroxide  1—5%  benzyl  alcohol  and
94.5—98.5%  other  ingredients
Kills  a  wide  variety  of
organisms  including  bacteria,
antibiotic  resistant  bacteria,
viruses  and  fungi
Allow  surface  to  remain  wet
1  min  to  kill  HIV-1,  HBV  and
HCV,  5  min  to  kill  Tb  and
10  min  to  kill  fungi
Pure  Green  24
(Pure  Green  LLC,
USA)
0.003%  Silver,
4.84%  citric  acid
95.151%  other  ingredients  Kills  a  wide  variety  of
organisms  including  bacteria,
antibiotic  resistant  bacteria,
viruses  and  fungi
Contact  time  varies  by
microorganisms;  remain
10  min  to  kill  norovirus
Beta  formula
(Kim
Laboratories,
Rantoul,  IL)
0.07%  Alkyl  dimethyl  benzyl  ammonium
chloride;  0.07%  alkyl  dimethyl
ethylbenzyl  ammonium  chloride
Fortiﬁed  with  proprietary
extracts  and  other
surfactants,  97%  inert
ingredients
Kills  a  wide  variety  of
organisms  including  bacteria,
viruses  and  fungi
Use  as  is.  Spray  and  wet
surface  for  1  min  and  wipe
out  remains
a As represented on the product labels.
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Figure  2  Flow  diagram  of  the  in  vitro  test  of  the  disinfectants  against  human  noroviruses  using  IMS  followed  by
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Geal-time  RT-PCR.
reviously  [16].  Fig.  2  shows  a  ﬂow  diagram  of
he sample  collection  and  the  IMS  procedure.  Sev-
ral concentrated  test  products  were  diluted  using
 ×  phosphate-buffered  saline  (PBS,  0.01  M,  pH  7.4,
ulbecco’s  modiﬁcation)  according  to  the  instruc-
ions  of  the  commercial  disinfectants.  Brieﬂy,  15  L
f the  20%  NV  stool  suspension  was  mixed  with
5 L  of  each  test  disinfectant  solution,  water,
0% ethanol,  or  1600  ppm  sodium  hypochlorite.  The
irus—disinfectant  (or  control)  mixture  was  quickly
ortexed  and  incubated  for  2,  4,  or  10  min  as  indi-
ated  by  the  instructions  on  the  product  labels.
mmediately following  the  exposure  period,  900  L
BS was  added  to  the  mixture,  and  a  half  volume
500 L)  was  removed  from  this  tube  and  added  to
s
p
I
a tube  containing  500  L  of  PBS  for  further  neutral-
zation of  the  reaction.
MS procedure
ne  milliliter  of  the  sample  collected  from  the
forementioned in  vitro  suspension  procedure
as mixed  with  20  L  (approximately  3  ×  107
eads)  of  the  NV  antibody-conjugated  beads
r 15  L  (approximately  2  ×  107 beads)  of  the
II.4 antibody-conjugated  magnetic  beads.  The
ample—bead  mixture  was  incubated  at  room  tem-
erature  for  2  min,  rolled  on  a Minilab  rotator  (Lab
nternational  Inc.,  Pittsburg,  PA)  at  room  temper-
ture for  1 h,  and  removed  from  the  roller.  The
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beads  with  captured  viruses  were  collected  with  a
PolyATtract® System  1000  (Promega,  Madison,  WI)
and washed  with  PBS.  The  beads  were  then  sus-
pended  in  50  L  of  1 ×  PBS  and  transferred  to  a
1.7-mL sterile  tube.
Heat-release RNA extraction and RT-qPCR
Heat-release  RNA  extraction  was  used  to  release
the RNA  as  described  previously  [18].  NV-speciﬁc
RT-qPCR was  performed  following  previously
described methods  [19]. GII.4  RNA  was  detected
using a  NoV  GII  broadly  reactive  RT-qPCR  assay
[20].  To  generate  a  standard  curve  for  the  NV
RNA quantiﬁcation,  a  full-length  NV  RNA  standard
was transcribed  in  vitro  from  a  NV  plasmid  cDNA.
Similarly,  a  Snow  Mountain  virus  (SMV,  GII.2  cluster)
RNA standard  was  generated  from  a  SMV  plasmid
and used  for  the  quantiﬁcation  of  the  GII.4  RNA.
The log  reduction  associated  with  the  exposure  to
each disinfectant  was  calculated  by  subtracting
the log-transformed  NoV  titer  for  each  product
from the  log-transformed  baseline  control.  The
average  log  reduction  for  each  disinfectant  was
calculated  from  the  replicate  trials  and  the  dupli-
cate reactions  per  sample.  If  no  viral  RNA  was
detected in  a  reaction,  we  used  half  of  the  detec-
tion limit  of  the  NoV  RT-qPCR  to  calculate  the  log
reduction.
Results
Sensitivity of the IMS/RT-qPCR
A  series  of  tenfold  dilutions  of  known  NV  titers
(3.5 ×  106 —  3.5  genomic  copies)  in  1  mL  PBS
were prepared  and  processed  by  IMS.  Following
IMS and  heat  release  RNA  extraction,  RT-qPCR
was used  to  determine  the  limit  of  detection  of
the NV  IMS/RT-qPCR.  The  NV  IMS/RT-qPCR  exhib-
ited an  endpoint  detection  in  the  10−4 dilution,
which corresponded  to  approximately  100  of  the
spiked  viruses.  Similarly,  the  detection  limit  for
GII.4 IMS/RT-qPCR  was  determined  to  be  6.9  ×  102
(Table  2).
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Table  2  Detection  limits  of  IMS  beads  combined  with  RT-q
Initial  genomic  copies Dilution
−1 
NV  3.5  ×  106 +  
GII.4  6.9  ×  106 +  P.  Liu  et  al.
ptimal quantity of IMS beads for the
oncentration of NoV
o  determine  the  optimal  quantity  of  IMS  beads
or the  separation  of  NVs,  different  volumes  (2  L,
 L,  10  L,  and  20  L)  of  NV  mAbs  conjugated
MS beads  were  added  to  1  mL  of  PBS  containing
pproximately  106 NVs.  The  four  different  vol-
mes exhibited  no  signiﬁcant  binding  activity  to  the
Vs as  detected  by  NV-speciﬁc  RT-qPCR  (data  not
hown), but  20  L  of  the  IMS  beads  bound  with  the
ighest  number  of  NVs,  and  increasing  the  amount
f IMS  beads  did  not  increase  the  binding  signal
etween the  IMS  beads  and  the  NVs.  Therefore,
0 L  of  NV  IMS  beads  in  a  1-mL  sample  was  used
n the  subsequent  experiments.  The  optimal  vol-
me of  GII.4  beads  was  determined  using  the  same
rocedure  that  was  used  for  NV,  and  this  procedure
evealed that  15  L  of  the  GII.4  IMS  beads  produced
he best  results.
n vitro efﬁcacies of the disinfectants
revious  in  vitro  experiments  in  our  laboratory
ave demonstrated  that  70%  ethanol  is  ineffec-
ive at  reducing  NV  RNA  and  that  1600-ppm  sodium
ypochlorite  exhibits  a  clear  NV  inactivation  effect
16]. In  the  present  study,  sodium  hypochlorite  at
 concentration  of  1600  ppm  produced  complete
nactivation of  NV  with  an  average  of  4.84-log
eduction and  also  completely  inactivated  GII.4
ith an  average  3.74-log  reduction  in  a  2-min  con-
act time.  In  contrast,  70%  ethanol  exhibited  mean
og reductions  of  0.81  and  0.14  for  NV  and  GII.4,
espectively. When  we  examined  the  efﬁcacies  of
ine commercial  disinfectant  products  and  one  pro-
otype disinfectant,  considerable  variations  in  the
iral RNA  log  reductions  produced  by  the  different
isinfectants against  NV  and  GII.4  were  observed.
he average  log  reductions  of  the  disinfectants
gainst NV  and  GII.4  ranged  from  −0.98  to  3.19  and
0.95 to  1.38,  respectively.  Ammonium  chloride-
ased disinfectants  exhibited  no  effect  against
ither NV  or  GII.4.  The  disinfectant  Oxivir-TB
JohnsonDiversey,  Sturtevant,  Wisconsin)  produced
mall log  reductions  of NoV;  1.11  and  0.94  log-
eductions against  NV  and  GII.4,  respectively  were
PCR.
−2  −3  −4  −5  −6
+  +  +  −  −
+  +  +  −  −
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Table  3  In  vitro  efﬁcacy  of  disinfectants  against  Norwalk  virus  (GI.1)  and  NoV  GII.4  strain.
Disinfectant  name Mean log  reduction  (SDa)
NV  GII.4
Ethanol  Control  0.81  (0.57)  0.14  (0.13)
Bleach  Control  4.84  (0.03)  3.74  (0.05)
Daesung  −0.20  (0.07)  −0.04  (0.06)
Ajax  0.06  (0.21)  −0.02  (0.04)
Clorox  Disinfectant  Wipes  −0.01  (0.22)  −0.95  (0.10)
Vital  Oxide  −0.98  (0.47)  −0.8  (0.65)
Aseptic-HB  −0.44  (0.17) −0.87 (0.08)
Namkang  −0.13  (0.22) −0.12 (0.17)
Lysol 2.29  (0.37) 0.21  (0.10)
Oxivir-TB  1.11  (0.08)  0.94  (0.13)
Pure  Green  24  −0.67  (0.07)  −0.73  (0.13)
Beta  formula  3.19  (0.67)  1.38  (0.40)
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bserved.  Lysol  (Reckitt  Benckiser,  UK),  with  the
ctive ingredient  of  lactic  acid,  produced  an  aver-
ge log-reduction  in  NV  of  2.29  and  an  average
og-reduction  in  GII.4  of  0.21.  Exposure  to  the  pro-
otype disinfectant  developed  by  Kim  Laboratories
nc. resulted  in  the  greatest  mean  reductions  of  NV
NA (3.19)  and  GII.4  RNA  (1.38).  Pure  Green  24  con-
aining  citric  acid  and  silver  iron  was  ineffective  in
educing the  NV  and  GII.4  RNA  titers  (Table  3).
iscussion
nanimate  surfaces  such  as  food  processing  sur-
aces, door  handles,  and  toilet  handles  are  known
o be  important  vehicles  for  NoV  transmission  [21],
nd the  use  of  effective  disinfectants  is  a criti-
al NoV  infection  control  strategy  [10]. Despite  the
mportant  role  of  disinfectants  in  the  control  of
oV transmission,  little  is known  about  the  efﬁ-
acies  of  disinfectants  in  reducing  the  spread  of
oV partially  because  of  the  lack  of  routine  and
eplicable culture-based  methods  and  small  ani-
al models  to  determine  intact  human  NoV.  Given
hese  circumstances,  most  studies  seeking  to  deter-
ine the  efﬁcacy  of  disinfectants  and  antiseptics
gainst NoV  have  employed  surrogate  caliciviruses,
ncluding feline  calicivirus  (FCV)  [22]  and  murine
orovirus  (MNV)  [23], to  estimate  the  effectiveness
f disinfectants  against  HuNoV.  However,  the  results
btained  using  surrogate  viruses  might  not  repre-
ent actual  efﬁcacy  against  HuNoV  strains.
Immunomagnetic  separation  in  which  mono-lonal or  polyclonal  antibodies  are  conjugated  to
agnetic  beads  and  used  to  isolate  and  concen-
rate speciﬁc  virus  particles  for  subsequent  PCR
mpliﬁcation  has  been  used  for  NoV  detection  in
o
s
s
tlinical  and  environmental  samples  [13—15]. IMS  is
ble to  effectively  remove  interfering  substances
rom clinical  or  environmental  samples  and  sepa-
ate them  from  the  speciﬁc  virus  particles.  This
rocess  ensures  that  the  nucleic  acids  detected
uring subsequent  PCR  ampliﬁcations  are  derived
rom  intact  virions  and  reduces  the  possibility  of
etecting disrupted  virus  particles  and  naked  RNA.
his technique  has  been  used  for  several  viruses
24—26]  and  is  particularly  appropriate  for  non-
ultivable  viruses  such  as  NoV.  Previous  studies
ave successfully  employed  IMS  and  RT-PCR  to
etect  NoV  particles  in  fecal  specimens  [15],  NoV-
ontaminated  water  [14], and  food  samples  [13]
nd  indicate  that  sensitivity  and  efﬁciency  of  this
ssay are  more  promising  than  those  of  available
ethods for  the  detection  of  NoV  in  stool  sam-
les [26]. For  example,  Gilpatrick  et  al.  used  an
MS/RT-PCR  assay  to  detect  Norwalk  virus  in  stool
amples  from  experimental  human  infections  and
ompared  this  assay  to  heat  release/RT-PCR  and  an
ntigen ELISA.  The  detection  limit  of  the  IMS/RT-
CR was  250—750  genomic  equivalents/ml  of  10%
tool suspension,  and  the  sensitivity  of  the  IMS/RT-
CR was  signiﬁcantly  better  than  those  of  the
eat release/RT-PCR  and  the  antigen  ELISA  [26].
n the  present  study,  we  applied  IMS  followed  by
T-qPCR  with  the  objective  of  detecting  intact
oV particles  from  samples  for  testing  the  efﬁ-
acy of  disinfectants  against  NV  and  GII.4  strains.
he monoclonal  antibody-coated  immunomagnetic
eads successfully  detected  NV  and  GII.4  in  stool
uspension  dilutions  containing  approximately  100
f the  respective  virus  particles  and  found  a sen-
itivity that  was  similar  to  that  of  the  previous
tudy [26].  Nonspeciﬁc  binding  by  magnetic  beads
o heterologous  viruses  has  been  reported  by  other
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investigators  [26,27], but  this  was  not  an  issue  in
the present  study  because  the  samples  in  this  study
contained  only  the  speciﬁc  NoV  genotype.  Addition-
ally,  two  levels  of  speciﬁcity  were  provided:  (1)  the
monoclonal  antibodies  used  in  this  study  exhibited
more  speciﬁc  binding  than  the  polyclonal  antibod-
ies [15],  and  (2)  the  RT-qPCR  used  speciﬁc  primers
and probes  for  NoV  ampliﬁcation.
The  traditional  methods  that  have  been  used
to evaluate  the  virucidal  activities  of  disinfectants
are based  on  cell  cultures  and  are  considered  to
be the  gold  standard.  However,  culturing  methods
are not  always  available  for  some  pathogens  such
as human  noroviruses.  In  such  situations,  virucidal
activity  is normally  tested  using  surrogate  viruses
that are  capable  of  growing,  but  the  test  results
from surrogates  do  not  represent  the  effects  of
disinfectants  against  the  non-cultivable  virus.  To
test the  effectiveness  of  disinfectants  against  non-
cultivable  viruses,  molecular  assays  such  as  PCR
are typically  used;  however,  one  major  concern
regarding PCR  is  that  presence  of  nucleic  acid  does
not indicate  the  presence  of  intact  virions  because
it is  possible  for  naked  nucleic  acid  to  be  detected
by PCR.  Some  investigators  [28]  have  sought  to
address this  issue  by  pretreating  samples  with
RNase H  under  the  assumption  that  the  RNase  will
degrade  the  naked  nucleic  acid  prior  to  the  applica-
tion of  PCR.  In  this  study,  we  addressed  this  issue  in
an alternative  manner;  we  used  immunomagnetic
beads conjugated  to  NV  monoclonal  antibodies  to
isolate the  virions  and  subsequently  used  real-time
PCR to  detect  the  viruses.
A previous  study  [16]  from  our  group  indicated
that ethanol  has  no  effect  against  human  Norwalk
virus; however,  in  the  present  study,  ethanol  pro-
duced  a  0.81  log-reduction  in  Norwalk  virus.  The
discrepancy  between  these  two  studies  is  the  result
of the  different  methodologies  used  to  determine
the efﬁcacies.  In  the  previous  study,  viral  RNA  was
extracted  from  NV  samples  that  were  treated  with
ethanol;  thus,  the  detection  of  viral  RNA  should
have been  indicative  of  the  presence  of  intact  viri-
ons, disrupted  virions,  and  naked  RNA.  In  contrast,
the ethanol-treated  NV  samples  in  this  study  were
processed  by  IMS  ﬁrst,  and  the  detection  of  viral
RNA thus  indicated  only  the  presence  of  intact
virions; hence,  the  viral  titers  were  lower  in  the
ethanol-treated  samples,  and  the  log  reduction  was
higher.
Several commercial  disinfectants  based  on  dif-
ferent concentrations  of  alkyl  dimethyl  benzyl
ammonium chloride  and/or  alkyl  dimethyl  ethyl-
benzyl  ammonium  chloride  failed  to  inactivate  NV
and GII.4  in  the  4-min  or  10-min  exposure  periods.
These results  are  consistent  with  those  of  a  previous
L
i
r
iP.  Liu  et  al.
tudy  that  reported  the  ineffectiveness  of  a similar
isinfectant  formulation  against  FCV,  a  surrogate
or HuNoV  [22]. However,  that  study  reported  that
lkyl dimethyl  ethylbenzyl  ammonium  chloride  for-
ulated with  other  additives  is  effective  against
CV [29], which  suggests  that  a  synergistic  effect
ight have  contributed  to  the  virucidal  activity.
nterestingly, nearly  all  of  the  disinfectants  that
se ammonium  chlorite  as  the  active  ingredient  in
his study  produced  negative  log  reductions  com-
ared to  the  baseline  control.  This  phenomenon
s likely  associated  with  two  factors:  (1)  ammo-
ium might  have  positive  effects  on  norovirus  RNA
ields as  reﬂected  in  a previous  study  in  which
ptimal concentrations  of  ammonium  were  found
o promote  the  RNA  expression  of  some  endome-
rial genes  [30], and  (2)  ammonium  likely  helps  the
emoval of  PCR  inhibitors  from  the  samples  [31].
ither or  both  of  these  factors  could  have  resulted
n higher  viral  RNA  titers  from  the  RT-qPCR  detec-
ions of  the  treated  samples  and  consequently  led
o negative  log  reductions  compared  to  the  baseline
ontrol.
Hydrogen  peroxide  has  been  widely  used
or microbial  inactivation.  Previous  studies  have
eported  the  effectiveness  of  hydrogen  peroxide
ompounds against  bacteria  [32], parasites  [33],
nd viruses  [34].  In  the  present  study,  Oxivir-TB
ith 0.5%  hydrogen  peroxide  exhibited  moderate
irucidal activities  against  both  NV  and  GII.4,  which
uggests that  hydrogen  peroxide  has  broad  spec-
rum antimicrobial  and  antiviral  activities.
Unsurprisingly,  Pure  Green  24  containing  citric
cid and  silver  iron  was  ineffective  against  NV  and
II.4 because  citric  acid  has  shown  mixed  viru-
idal activities  previous  studies.  For  example,  2%
itric acid  was  found  effective  in  the  inactivation
f both  foot-and-mouth  disease  virus  and  African
wine fever  virus  dried  on  a wood  surface  for  30  min
t 22 ◦C  [35], but  a  suspension  test  indicated  that  a
itric acid  compound  was  ineffective  against  avian
nﬂuenza viruses  at  low  temperature  [36], and  a
ontrolled clinical  trial  of  hand  disinfection  with
n antiviral  hand  treatment  containing  2%  citric
cid in  62%  ethanol  did  not  signiﬁcantly  reduce  rhi-
ovirus (RV)  infection  or  RV-related  common  cold
llnesses  in  young  adult  volunteers  [37]. As  norovirus
s one  of  the  pathogens  that  is  most  resistant  to
isinfectants,  it is  less  likely  to  be  inactivated  by
isinfectants  with  citric  acid  as  the  active  ingredi-
nt than  the  aforementioned  viruses.
The  prototype  disinfectant  developed  by  Kimaboratories  Inc.,  produced  a  3.19  log-reduction
n NV  and  a 1.38  log-reduction  in  GII.4,  and  these
esults  indicate  the  promising  activity  of  this  dis-
nfectant  against  HuNoV.  Together  with  the  results
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[etermining  the  Efﬁcacy  of  Disinfectants  by  IMS  an
rom  other  effective  disinfectants  used  in  this
tudy,  it  is  obvious  that  GII.4  is  more  resistant
o disinfectants  than  NV.  These  observation  coin-
ides with  those  of  previous  epidemiological  studies
n which  GII.4  strains  were  found  to  have  caused
reater numbers  of  outbreaks  than  GI  viruses  world-
ide since  the  1990  s  [38—40].  The  persistence  of
II.4 in  the  environments  has  been  reported  pre-
iously  [8],  and  the  evidence  for  the  resistance
f GII.4  to  disinfectants  from  the  present  study
ight help  to  elucidate  the  epidemiological  dispar-
ty between  the  GII.4  and  GI  viruses.
onclusion
he  IMS/RT-qPCR  assay  developed  in  this  study
ppears to  be  an  effective  method  for  the  removal
f PCR-inhibiting  substances  from  samples  and
he subsequent  detection  of  intact  virions  using
T-qPCR.  To  our  knowledge,  this  is  the  ﬁrst  break-
hrough address  the  issues  of  PCR  inhibitors  while
valuating  disinfectant  products  using  molecular
ssays. The  current  prototype  disinfectant  devel-
ped by  Kim  Laboratories  was  the  most  efﬁcacious
mong the  tested  disinfectants  in  the  inactiva-
ion of  HuNoV,  and  the  disinfectants  with  active
ngredients of  alkyl  dimethyl  benzyl  ammonium
hloride and/or  alkyl  dimethyl  ethylbenzyl  ammo-
ium exhibited  the  worst  efﬁcacies  against  human
oroviruses.
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